Please assess the completion status of the following clinical trial:

Trial Title: On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Women, aged 18-38~* English speaking~* Able to consent, literate~* Access to smart phone throughout study~* History of regular menses~* Documented baseline cycle with ovulation~* Not currently using or needing hormonal contraception~* Not currently using or needing regular NSAIDS~* Able to commit to frequency of study visits~Exclusion Criteria:~* Currently or recently (\<2months) pregnant~* Currently or recent (\<2months) breastfeeding~* Current or recent (\<2months) use of hormonal medication~* Regular NSAID use~* Known cardiac risk factors (e.g. personal history of obesity, HTN, cardiac disease, diabetes)~* BMI \> 30, as some studies have shown decreased efficacy of ulipristal in obese women37~* Allergy or previous unacceptable side effects with study medications

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 38 Years
- Healthy Volunteers: t

Study Arms:
- Ulipristal 30mg plus Meloxicam 15mg (Type: EXPERIMENTAL): Each study participant will complete one menstrual cycle without medication. Her second menstrual cycle, each study participant will receive ulipristal acetate plus meloxicam at peak fertility.

Based on this trial design, predict the completion outcome and termination type (if applicable).